Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
Clinical trial NCT04487444 · TERMINATED
Trial details
- NCT number
- NCT04487444
- Sponsor
- Rhode Island Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2023-02-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.